Skip to main content
Kamada Ltd. logo

Kamada Ltd. — Investor Relations & Filings

Ticker · KMDA ISIN · IL0010941198 TA Manufacturing
Open in API
Filings indexed 824 across all filing types
Latest filing 2025-01-08 Regulatory Filings
Country IL Israel
Listing TA KMDA

About Kamada Ltd.

https://www.kamada.com

Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.

Recent filings

Filing Released Lang Actions
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'FORM 6-K' and is a 'Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934' for the month of January 2025. Form 6-K filings in the US context typically contain material information that a foreign private issuer is required to disclose in its home country or to a stock exchange. The content primarily consists of an announcement affirming 2024 financial guidance and providing 2025 guidance, along with an attached 'Company's Presentation – January 2025' (Exhibit 99.2). This structure—a brief filing summarizing key financial updates and attaching supporting materials like guidance affirmations and presentations—is characteristic of an Earnings Release (ER) or a general regulatory filing. Since the document provides detailed financial guidance affirmation and outlook, it strongly aligns with the purpose of an Earnings Release (ER). While it is filed on Form 6-K, the *content* is an earnings/guidance announcement, which maps best to 'ER' (Earnings Release) or potentially 'RPA' (Report Publication Announcement) if it were just announcing the attached presentation. However, the core substance is the financial guidance update, making ER the most appropriate classification for the substance being reported, even if the regulatory wrapper is 6-K. Given the options, ER captures the primary financial news being disseminated.
2025-01-08 English
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
Regulatory Filings Classification · 1% confidence The document is very short (2181 characters) and explicitly states, "Attached hereto is a report on*Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025* 1__isa.pdf". This structure—a brief filing announcing the publication of a separate, attached report—fits the definition of a Report Publication Announcement (RPA) according to Rule 2 (The "MENU VS MEAL" RULE). The content suggests the attached PDF contains earnings or guidance updates, but this filing itself is merely the announcement mechanism used for the Israel Securities Authority (ISA) and Tel Aviv Stock Exchange (TASE).
2025-01-08 English
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
AGM Information Classification · 1% confidence The document is explicitly titled 'FORM 6-K' and reports on events that occurred during the 'Month of December 2024'. The content details the proceedings and outcomes of an 'Annual General Meeting of Shareholders' held on December 11, 2024, specifically listing the approved proposals, including the re-election of directors and the ratification of auditors. Since the document reports the *results* of the shareholder vote from the AGM, it aligns best with the Declaration of Voting Results & Voting Rights Announcements (DVA). Although it relates to an AGM, the core function here is reporting the voting outcomes, not providing the presentation materials (AGM-R) or the proxy solicitation (PSI). The Form 6-K itself is a general regulatory filing, but DVA is the most specific category for reporting voting results.
2025-01-08 English
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
Report Publication Announcement Classification · 1% confidence The document is a very short filing (1985 characters) submitted to the Israel Securities Authority and the Tel Aviv Stock Exchange (TASE). It explicitly states: "Attached hereto is a report on*Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025* *2__isa.pdf*". This structure—a brief announcement stating that a full report is attached or published—fits the definition of a Report Publication Announcement (RPA) according to the 'MENU VS MEAL' rule. While the content relates to financial guidance (which could suggest ER or MDA), the format is purely an announcement of publication.
2025-01-08 English
Annual General Meeting Results
AGM Information Classification · 1% confidence The document is explicitly titled 'FORM 6-K' and reports on events that occurred during the 'Month of December 2024'. The content details the proceedings and outcomes of an 'Annual General Meeting of Shareholders' held on December 11, 2024, specifically listing the approved proposals, including the re-election of directors and the ratification of auditors. Since the document reports the *results* of the shareholder vote from the AGM, it aligns best with the Declaration of Voting Results & Voting Rights Announcements (DVA). Although it relates to an AGM, the core function here is reporting the voting outcomes, not providing the presentation materials (AGM-R) or the proxy solicitation (PSI). The Form 6-K itself is a general regulatory filing, but DVA is the most specific category for reporting voting results.
2024-12-11 English
Annual General Meeting Results
AGM Information Classification · 1% confidence The document explicitly states "Annual General Meeting Results" in the title and body. It is a short regulatory filing (1745 chars) that announces the results and explicitly states "Attached hereto is a report on *Annual General Meeting Results* *2__isa.pdf*". According to Rule 2 (The 'Menu vs Meal' Rule), when a document is short and announces that a report is attached or published, it should be classified as a Report Publication Announcement (RPA) rather than the full report itself. However, since the content is specifically about the *results* of the AGM, and AGM-R is defined as 'Presentations and materials shared during the Annual General Meeting (AGM)', this filing is the official announcement/material related to the AGM results. Given the specific nature of the content (AGM Results) and the existence of the AGM-R code, I will prioritize the content over the strict RPA rule, as this is the official result disclosure for the AGM. If AGM-R was not available, RPA would be the choice. Since the content is the result itself, AGM-R is the most accurate fit for the subject matter.
2024-12-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.